Sarah Pringle

Power begets power, and women running the show could be the most effective solution for changing the makeup of private equity.

Including a fifth acquisition set to close in two weeks, the retina-focused PPM produces combined EBITDA of $80m-plus.

A lot of deals going on that crisscross the healthcare and industrials sectors

Companies providing services to drug-makers are particularly hot. Sales of recent assets have commanded EBITDA multiples in the mid-teens to 20x.

Comar, now generating over $200m in revenue, will target select M&A opportunities within the scientific molding, micromolding, silicon and sharps areas.

PRN's Houlihan Lokey-run auction gets underway as Gryphon Investors gears up to sell the even-larger Cora Physical Therapy.

Pharmacy company ExactCare hits the block.

Nautic in March 2016 recapitalized ExactCare, which specializes in serving complex patients in their homes.

The Boca Raton, Florida, firm eyes potential opportunities for investment in eyecare, behavioral health and across the orthopedic supply chain.

In healthcare, private equity firms are buzzing around the primary care vertical.